(WASHINGTON, D.C.) — CHPA Senior Vice President of Dietary Supplements Duffy MacKay today released the following statement in response to results from a recent trial finding that people ages 60 and older who took a daily multivitamin showed an estimated 3.1 fewer years of memory loss than those who took a placebo. These results are the second time a multivitamin clinical trial within the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) reached the same conclusion.
“When it comes to nutrition, even those individuals with the healthiest diets often fail to reach the recommended daily intake level for vitamins and nutrients. As we age, achieving that goal becomes even more important in order to protect memory and cognition, which is why CHPA is pleased to once again see promising results emerge from this clinical trial.
“These results are certainly important, as there is an urgent need to identify strategies to preserve cognitive function and reduce the burden of dementia on families and society. This clinical trial reinforces the important role supplements play in helping adults meet their nutrient needs, which is a critical part of healthy aging for the mind and body.
“Last year, participants in CHPA’s Regulatory, Scientific and Quality Conference had the opportunity to hear directly from Mark Espeland, PhD, Principal Investigator on the 2022 COSMOS-Mind trial results, and we are excited to see this additional study published. Scientific evidence grows in increments, and this study is an important component in strengthening the beneficial role of safe, accessible, and affordable dietary supplements that can be used to optimize health through self-care.”
